BLISS Platform
Cross-source consensus on BLISS Platform from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Evidence quality
Other
Other
Highlighted claims
- The BLISS project is scheduled to run from May 2025 to April 2030. — Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems data
- BLISS is a data-linkage research database designed to integrate completed multiple myeloma randomised clinical trials with national healthcare systems data. — Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems data
- BLISS aims to determine whether routinely collected healthcare data can support extended follow-up of blood cancer trials at a quality comparable with trial-specific follow-up. — Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems data
- BLISS addresses an evidence gap because no prior data evaluate routinely collected healthcare systems data for outcome ascertainment in blood cancer clinical trials. — Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems data
- The initial BLISS protocol covers linkage to data held in England, while future linkage to Wales and Scotland would require a substantial amendment to ethical approvals. — Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems data